---
name: manuscript-review
description: |
  æ¨¡æ“¬åŒè¡Œå¯©ç¨¿èˆ‡å ±å‘ŠæŒ‡å¼•åˆè¦æ€§æª¢æŸ¥æ¡†æ¶ã€‚
  LOAD THIS SKILL WHEN: peer reviewã€åŒè¡Œå¯©æŸ¥ã€reviewerã€å¯©ç¨¿ã€reporting guidelinesã€CONSORTã€STROBEã€PRISMAã€CAREã€critiqueã€æª¢æŸ¥ç¨¿ä»¶ã€ç¨¿ä»¶å•é¡Œ
  CAPABILITIES: ç´”æŒ‡ä»¤æŠ€èƒ½ï¼Œæ­é… read_draft MCP tool è®€å–è‰ç¨¿å…§å®¹ã€‚LLM ç”¨é†«å­¸çŸ¥è­˜åšå¯©æŸ¥ï¼Œæ¯” regex æ›´æº–ç¢ºã€‚
---

# ç¨¿ä»¶å¯©æŸ¥èˆ‡å ±å‘ŠæŒ‡å¼•æŠ€èƒ½

## è¨­è¨ˆæ„åœ–

> **ç‚ºä»€éº¼é€™ä¸æ˜¯ MCP Toolï¼Ÿ**
> Peer review å’Œ reporting guideline åˆè¦æ€§æª¢æŸ¥éœ€è¦ã€Œç†è§£ã€å…§å®¹ï¼Œä¸æ˜¯é—œéµå­—åŒ¹é…ã€‚
> - Hard-coded regex æª¢æŸ¥ã€Œæœ‰æ²’æœ‰ IRBã€â†’ åªèƒ½æ‰¾åˆ° "IRB" é—œéµå­—
> - LLM å¯©æŸ¥ â†’ èƒ½ç†è§£ "æœ¬ç ”ç©¶ç¶“å°åŒ—æ¦®æ°‘ç¸½é†«é™¢å€«ç†å§”å“¡æœƒæ ¸å‡†" ä¹Ÿæ˜¯ ethics approval
>
> è³‡æ–™å­˜å–ï¼ˆè®€è‰ç¨¿ï¼‰ç”¨ `read_draft` MCP toolï¼Œå¯©æŸ¥é‚è¼¯ç”± LLM + æ­¤ skill çš„ domain knowledge å®Œæˆã€‚

---

## é©ç”¨æƒ…å¢ƒ

| è§¸ç™¼èª | æ“ä½œ |
|--------|------|
| ã€Œå¹«æˆ‘å¯©æŸ¥ä¸€ä¸‹è‰ç¨¿ã€ | â†’ Peer Review Framework |
| ã€Œåƒ reviewer ä¸€æ¨£çœ‹çœ‹ã€ | â†’ Peer Review Framework |
| ã€ŒCONSORT åˆè¦å—ã€ | â†’ Reporting Guideline Framework |
| ã€Œç¼ºäº†ä»€éº¼ STROBE é …ç›®ã€ | â†’ Reporting Guideline Framework |
| ã€ŒæŠ•ç¨¿å‰æª¢æŸ¥ã€ | â†’ å…©å€‹ Framework éƒ½ç”¨ |

---

## æ­é… MCP Tools

| å·¥å…· | ç”¨é€” |
|------|------|
| `read_draft` | **å¿…ç”¨** â€” è®€å–è¦å¯©æŸ¥çš„è‰ç¨¿å…§å®¹ |
| `list_drafts` | åˆ—å‡ºæ‰€æœ‰è‰ç¨¿é¸æ“‡è¦å¯©æŸ¥çš„ |
| `count_words` | å­—æ•¸çµ±è¨ˆ |
| `check_formatting` | æœŸåˆŠæ ¼å¼é‡åŒ–æª¢æŸ¥ï¼ˆå­—æ•¸/å¼•ç”¨æ•¸/åœ–è¡¨æ•¸ vs é™åˆ¶ï¼‰|
| `check_manuscript_consistency` | è·¨æ–‡ä»¶ä¸€è‡´æ€§æª¢æŸ¥ |
| `get_section_template` | å°ç…§ section å¯«ä½œæŒ‡å— |

---

## Framework 1: Peer Review (æ¨¡æ“¬åŒè¡Œå¯©æŸ¥)

### å·¥ä½œæµç¨‹

```
Step 1: read_draft(filename) â†’ å–å¾—è‰ç¨¿å…§å®¹
Step 2: æŒ‰ä»¥ä¸‹ 4 å¤§é¢å‘é€ä¸€å¯©æŸ¥
Step 3: è¼¸å‡ºçµæ§‹åŒ–å¯©æŸ¥å ±å‘Š
```

### å¯©æŸ¥é¢å‘

#### 1. Structure (çµæ§‹)

æª¢æŸ¥é …ç›®ï¼š

| é …ç›® | è©•ä¼°æ–¹å¼ | Major/Minor |
|------|----------|-------------|
| å¿…è¦ç« ç¯€æ˜¯å¦é½Šå…¨ | å°ç…§ EXPECTED_SECTIONS æ¸…å–® | Major (ç¼ºå°‘) |
| Abstract æ˜¯å¦çµæ§‹åŒ– | æœ‰ç„¡ Background/Methods/Results/Conclusions | Minor |
| é‚è¼¯é †åº | Introduction â†’ Methods â†’ Results â†’ Discussion | Major (äº‚åº) |

**EXPECTED_SECTIONS by journal type:**

| Journal Type | Required Sections |
|-------------|-------------------|
| General | Abstract, Introduction, Methods, Results, Discussion, References |
| Specialty | Same as General |
| High-Impact | + Limitations, Conclusions (ç¨ç«‹ç« ç¯€) |

#### 2. Methods (æ–¹æ³•)

| é …ç›® | æ„ç¾© | Major/Minor |
|------|------|-------------|
| Ethics/IRB statement | å€«ç†å¯©æŸ¥æ ¸å‡† | **Major** |
| Statistical methods | çµ±è¨ˆåˆ†ææè¿° | **Major** |
| Sample size justification | æ¨£æœ¬æ•¸ä¾æ“š/power analysis | Minor |
| Primary outcome definition | ä¸»è¦çµæœæŒ‡æ¨™æ˜ç¢ºå®šç¾© | Minor |
| Inclusion/exclusion criteria | ç´å…¥æ’é™¤æ¨™æº– | Minor |

#### 3. Statistics (çµ±è¨ˆ)

| é …ç›® | æ„ç¾© | Major/Minor |
|------|------|-------------|
| P-value reporting | å ±å‘Šç²¾ç¢º p-value (éåªå¯« p<0.05) | Minor |
| Confidence intervals | æ•ˆæœä¼°è¨ˆå€¼é™„ 95% CI | **Major** |
| Multiple comparisons | å¤šé‡æ¯”è¼ƒæ ¡æ­£ (Bonferroni/FDR) | Minor |
| Effect size reporting | è‡¨åºŠæ„ç¾© vs çµ±è¨ˆé¡¯è‘— | Minor |

#### 4. Writing Quality (å¯«ä½œå“è³ª)

| é …ç›® | æ„ç¾© | Major/Minor |
|------|------|-------------|
| Limitations section | æœ‰ç¨ç«‹çš„é™åˆ¶æ®µè½ | **Major** |
| Causal language in observational | è§€å¯Ÿæ€§ç ”ç©¶ä¸æ‡‰ä½¿ç”¨å› æœç”¨èª | **Major** |
| Word count | ç¬¦åˆæœŸåˆŠå­—æ•¸é™åˆ¶ | Minor |
| Reference density | å¼•ç”¨å¯†åº¦é©ç•¶ | Minor |
| Hedging language | çµè«–æ˜¯å¦éåº¦å¼·åŠ› | Minor |

### åš´é‡ç¨‹åº¦åˆ¤æ–·

```
Major Issues = Reviewer å¯èƒ½è¦æ±‚ major revision æˆ– reject
Minor Issues = Reviewer æœƒå»ºè­°æ”¹å–„ä½†ä¸å½±éŸ¿æ¥å—

Major â‰¥ 3  â†’ ğŸ”´ Major revision required
Major 1-2  â†’ ğŸŸ¡ Major revision
Major = 0  â†’ âœ… Minor revision or accept
```

### è¼¸å‡ºçµæ§‹

```markdown
# ğŸ“ Peer Review Report

**Draft:** {filename}
**Journal Type:** {general/specialty/high-impact}
**Focus:** {comprehensive/methods/statistics/writing}

---

## Major Issues (X items)

### 1. [Category] {issue_title}
- **Problem:** {description}
- **Suggestion:** {specific fix}

## Minor Issues (Y items)

### 1. [Category] {issue_title}
- **Problem:** {description}
- **Suggestion:** {specific fix}

---

**Recommendation:** {âœ…/ğŸŸ¡/ğŸ”´}

ğŸ’¡ Use `check_reporting_guidelines` skill for guideline-specific checks.
```

---

## Framework 2: Reporting Guideline Compliance (å ±å‘ŠæŒ‡å¼•åˆè¦)

### å·¥ä½œæµç¨‹

```
Step 1: read_draft(filename) â†’ å–å¾—è‰ç¨¿å…§å®¹ï¼ˆæ”¯æŒå¤šæª”æ¡ˆé€—è™Ÿåˆ†éš”ï¼‰
Step 2: è‡ªå‹•åµæ¸¬æˆ–ç”±ä½¿ç”¨è€…æŒ‡å®šé©ç”¨çš„ guideline
Step 3: é€ä¸€æª¢æŸ¥ checklist é …ç›®
Step 4: è¼¸å‡ºåˆè¦å ±å‘Š
```

### Auto-Detection Rules

| è‰ç¨¿ç‰¹å¾µ | é©ç”¨æŒ‡å¼• |
|----------|----------|
| randomized, RCT, blinded, placebo | **CONSORT** |
| systematic review, meta-analysis, PRISMA | **PRISMA** |
| case report, case presentation | **CARE** |
| å…¶ä»–ï¼ˆobservational, cohort, case-controlï¼‰ | **STROBE** |

---

### ğŸ“‹ CONSORT Checklist (RCT, 21 items)

| Section | Item | æª¢æŸ¥é‡é» |
|---------|------|----------|
| Title | 1. Identified as RCT | æ¨™é¡ŒåŒ…å« "randomised/randomized" |
| Abstract | 2. Structured abstract | Background, Methods, Results, Conclusions |
| Introduction | 3. Background & rationale | ç§‘å­¸èƒŒæ™¯å’Œè§£é‡‹é‚è¼¯ |
| Introduction | 4. Specific objectives/hypotheses | å…·é«”ç›®çš„æˆ–å‡èªª |
| Methods | 5. Trial design | æè¿°è©¦é©—è¨­è¨ˆ (parallel, crossover, factorial) |
| Methods | 6. Eligibility criteria | åƒèˆ‡è€…çš„ç´å…¥æ’é™¤æ¨™æº– |
| Methods | 7. Interventions | æ¯çµ„ä»‹å…¥æ–¹å¼çš„å……åˆ†æè¿° |
| Methods | 8. Outcomes defined | é å…ˆæŒ‡å®šçš„ä¸»è¦å’Œæ¬¡è¦çµæœ |
| Methods | 9. Sample size determination | æ¨£æœ¬æ•¸å¦‚ä½•æ±ºå®š |
| Methods | 10. Randomization | Sequence generation æ–¹æ³• |
| Methods | 11. Allocation concealment | åˆ†é…éš±åŒ¿æ©Ÿåˆ¶ |
| Methods | 12. Blinding | èª°è¢«ç›²åŒ– (participants, care providers, outcome assessors) |
| Methods | 13. Statistical methods | ä¸»è¦å’Œæ¬¡è¦çµæœçš„çµ±è¨ˆæ–¹æ³• |
| Results | 14. Participant flow | Flow diagram (enrollment, allocation, follow-up, analysis) |
| Results | 15. Recruitment dates & follow-up | æ‹›å‹Ÿå’Œè¿½è¹¤çš„æ—¥æœŸ |
| Results | 16. Baseline data | å„çµ„çš„åŸºç·šäººå£å­¸å’Œè‡¨åºŠç‰¹å¾µ |
| Results | 17. Number analysed | æ¯çµ„åˆ†æçš„äººæ•¸ (ITT/PP) |
| Results | 18. Outcomes & estimation | æ¯å€‹çµæœçš„æ•ˆæœä¼°è¨ˆå’Œç²¾ç¢ºåº¦ (95% CI) |
| Results | 19. Harms | ä¸è‰¯äº‹ä»¶ |
| Discussion | 20. Interpretation | çµæœçš„è§£é‡‹ã€é™åˆ¶ã€external validity |
| Other | 21. Registration & protocol | è©¦é©—è¨»å†Š (ClinicalTrials.gov) å’Œ protocol |

---

### ğŸ“‹ STROBE Checklist (Observational, 16 items)

| Section | Item | æª¢æŸ¥é‡é» |
|---------|------|----------|
| Title | 1. Study design in title/abstract | æ¨™é¡Œæˆ–æ‘˜è¦æŒ‡å‡ºç ”ç©¶è¨­è¨ˆ |
| Introduction | 2. Background/rationale | ç§‘å­¸èƒŒæ™¯å’Œç†ç”± |
| Introduction | 3. Objectives | å…·é«”ç›®çš„å’Œå‡èªª |
| Methods | 4. Study design | ç ”ç©¶è¨­è¨ˆçš„é—œéµå…ƒç´  |
| Methods | 5. Setting | åœ°é»ã€æ—¥æœŸã€æ‹›å‹Ÿã€è¿½è¹¤ |
| Methods | 6. Participants | ç´å…¥æ’é™¤æ¨™æº–ã€ä¾†æºã€æ–¹æ³• |
| Methods | 7. Variables | çµæœè®Šé …ã€æš´éœ²å› å­ã€æ··æ·†å› å­ |
| Methods | 8. Data sources/measurement | è³‡æ–™ä¾†æºå’Œæ¯å€‹è®Šé …çš„æ¸¬é‡æ–¹æ³• |
| Methods | 9. Bias | è™•ç†æ½›åœ¨åèª¤çš„æ–¹æ³• |
| Methods | 10. Study size | æ¨£æœ¬æ•¸å¦‚ä½•æ±ºå®š |
| Methods | 11. Statistical methods | çµ±è¨ˆæ–¹æ³•å’Œæ§åˆ¶æ··æ·†çš„æ–¹æ³• |
| Results | 12. Participants | æ¯éšæ®µçš„äººæ•¸å’Œä¸åƒèˆ‡çš„åŸå›  |
| Results | 13. Descriptive data | åƒèˆ‡è€…ç‰¹å¾µå’Œæš´éœ²è³‡è¨Š |
| Results | 14. Outcome data & main results | çµæœå’Œæ•ˆæœä¼°è¨ˆ |
| Discussion | 15. Interpretation | çµæœè§£é‡‹ã€é™åˆ¶ã€generalizability |
| Other | 16. Funding | è³‡é‡‘ä¾†æº |

---

### ğŸ“‹ PRISMA Checklist (Systematic Review, 17 items)

| Section | Item | æª¢æŸ¥é‡é» |
|---------|------|----------|
| Title | 1. Identify as systematic review | æ¨™é¡Œæ¨™æ˜ systematic review |
| Abstract | 2. Structured summary | çµæ§‹å¼æ‘˜è¦ |
| Introduction | 3. Rationale & objectives | ç†ç”±å’Œå…·é«”ç ”ç©¶å•é¡Œ (PICO) |
| Methods | 4. Protocol & registration | Protocol å’Œè¨»å†Š (PROSPERO) |
| Methods | 5. Eligibility criteria | ç ”ç©¶çš„ç´å…¥æ’é™¤æ¨™æº– |
| Methods | 6. Information sources | æœå°‹çš„è³‡æ–™åº«å’Œæ—¥æœŸ |
| Methods | 7. Search strategy | å®Œæ•´çš„é›»å­æœå°‹ç­–ç•¥ |
| Methods | 8. Study selection | ç¯©é¸æµç¨‹ã€ç¨ç«‹é›™äººç¯©é¸ |
| Methods | 9. Data extraction | è³‡æ–™èƒå–éç¨‹ |
| Methods | 10. Risk of bias assessment | åèª¤é¢¨éšªè©•ä¼°æ–¹æ³• |
| Methods | 11. Synthesis methods | åˆæˆæ–¹æ³•å’Œç•°è³ªæ€§è©•ä¼° |
| Results | 12. Study selection flow | PRISMA flow diagram |
| Results | 13. Study characteristics | å„ç ”ç©¶ç‰¹å¾µå’Œåèª¤è©•ä¼° |
| Results | 14. Synthesis results | åˆæˆçµæœå’Œ forest plot |
| Results | 15. Heterogeneity | ç•°è³ªæ€§è©•ä¼° (IÂ², Q test) |
| Discussion | 16. Summary & limitations | è­‰æ“šæ‘˜è¦å’Œé™åˆ¶ |
| Other | 17. Registration number | PROSPERO æˆ–å…¶ä»–è¨»å†Šè™Ÿ |

---

### ğŸ“‹ CARE Checklist (Case Report, 13 items)

| Section | Item | æª¢æŸ¥é‡é» |
|---------|------|----------|
| Title | 1. Identify as case report | æ¨™é¡Œæ¨™æ˜ "case report" |
| Abstract | 2. Key information summary | åŒ…å«ä»‹ç´¹ã€æè¿°å’Œè¨è«–çš„æ‘˜è¦ |
| Introduction | 3. Background with references | æ–‡ç»å¼•ç”¨çš„èƒŒæ™¯ |
| Patient | 4. Demographics | ç—…äººå¹´é½¡ã€æ€§åˆ¥ã€ç¨®æ— |
| Patient | 5. Chief complaints | ä¸»è¨´å’Œç—‡ç‹€ |
| Patient | 6. Medical history | ç›¸é—œç—…å²å’Œåˆä½µç—‡ |
| Patient | 7. Physical examination | ç›¸é—œèº«é«”æª¢æŸ¥ç™¼ç¾ |
| Clinical | 8. Diagnostic assessment | è¨ºæ–·æ–¹æ³•ã€æŒ‘æˆ°å’Œæ¨ç† |
| Clinical | 9. Intervention | ä»‹å…¥æªæ–½çš„é¡å‹å’Œç®¡ç† |
| Clinical | 10. Follow-up & outcome | è¿½è¹¤å’Œçµæœ |
| Discussion | 11. Strengths & limitations | è¨è«–å„ªå‹¢å’Œé™åˆ¶ |
| Discussion | 12. Rationale for conclusions | çµè«–çš„ä¾æ“š |
| Patient | 13. Informed consent | ç—…äººåŒæ„è²æ˜ |

---

### è¼¸å‡ºçµæ§‹

```markdown
# ğŸ“‹ {GUIDELINE_NAME} Checklist

**Files checked:** {filenames}
**Guideline:** {auto-detected or specified}

## Summary
- **Compliance:** X/Y items (Z%)
- âœ… Found: X
- âŒ Not found: Y

## Checklist by Section

### {Section Name}
| # | Item | Status | Notes |
|---|------|--------|-------|
| 1 | {description} | âœ…/âŒ | {where found or what's missing} |

(repeat for all sections)

## âš ï¸ Action Items

1. **{Missing Item}** â€” {suggestion for how to add}
2. ...

---
ğŸŸ¢ Compliance â‰¥ 80%: Good shape for submission
ğŸŸ¡ Compliance 60-80%: Needs attention
ğŸ”´ Compliance < 60%: Significant gaps to address
```

---

## âš ï¸ ä½¿ç”¨åŸå‰‡

1. **LLM å¯©æŸ¥ > regex åŒ¹é…** â€” ç†è§£èªæ„ï¼Œä¸è¦åªæ‰¾é—œéµå­—
2. **æ°¸é å…ˆè®€è‰ç¨¿** â€” ç”¨ `read_draft` MCP tool å–å¾—å¯¦éš›å…§å®¹
3. **Major/Minor åˆ†é¡è¦æº–ç¢º** â€” Major = å¯èƒ½è¢« rejectï¼ŒMinor = æ”¹å–„å»ºè­°
4. **çµ¦å…·é«”ä¿®å¾©å»ºè­°** â€” ä¸åªæŒ‡å‡ºå•é¡Œï¼Œèªªæ˜æ€éº¼ä¿®
5. **èˆ‡ `check_formatting` äº’è£œ** â€” æœ¬ skill åšè³ªæ€§å¯©æŸ¥ï¼Œ`check_formatting` tool åšé‡åŒ–æª¢æŸ¥
6. **Checklist é …ç›®è¦çœ‹èªæ„** â€” ä¾‹å¦‚ã€Œinformed consentã€å¯èƒ½å¯«æˆã€ŒåŒæ„æ›¸ã€ã€ŒçŸ¥æƒ…åŒæ„ã€
7. **å¤šæª”æ¡ˆæ”¯æŒ** â€” ç”¨æˆ¶å¯èƒ½ Introduction å’Œ Methods åœ¨ä¸åŒæª”æ¡ˆ

---

## ç›¸é—œæŠ€èƒ½

- `draft-writing` â€” æ’°å¯«/ä¿®æ”¹è‰ç¨¿ï¼ˆå¯©æŸ¥å‰ï¼‰
- `academic-debate` â€” æŒ‘æˆ°ç ”ç©¶ä¸»å¼µçš„å¼·åº¦
- `concept-development` â€” æ¦‚å¿µç™¼å±•å’Œé©—è­‰
- `word-export` â€” æŠ•ç¨¿å‰åŒ¯å‡º Word
